STAT3, a member of signal transducers and activators of transcription (STATs) originally discovered as mediators in cytokine signaling pathways, plays an active role in oncogenesis. However, the function of STAT3 in signaling multistage carcinogenesis, especially in transformation of tumor-promotion sensitive epithelial cells has not been elucidated. The present study demonstrates that STAT3 is activated in interleukin-6 induced transformation in mouse skin epithelial cells. DNA binding and transcriptional activities of STAT3 were signi®cantly increased by interleukin-6. This induced anchorage-independent transformation in tumorpromotion sensitive JB6 mouse skin P+ cells but not in the resistant variant P7 cells. Two forms of dominant negative STAT3 (mutant of transcriptional domain, mF, or DNA-binding domain, mD) were stably transfected into P+ cells. Activation of STAT3 was abolished and importantly, interleukin-6 induced anchorage-independent growth was absent in both mutant STAT3 transfectants. To determine the genes targeted by STAT3, three matrix metalloproteinase proteins linked with carcinogenesis of epithelial cells were analysed. Both basal and interleukin-6 induced expression of collagenase I and stromelysin I, but not gelatinase A, were inhibited in the mutant STAT3 transfectants. Furthermore, transfection of a wild type STAT3 restored STAT3 transactivation and response to interleukin-6 induced transformation in mutant STAT3 transfectants, which up-regulated collagenase I and stromelysin I as well. Together, these results provide the ®rst evidence that STAT3 activation is required in the progression of multistage carcinogenesis of mouse skin epithelial cells, and matrix metalloproteinases are actively involved in STAT3-mediated cell transformation.
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Introduction
Carcinogenesis is a multistage process that involves multiple genetic and epigenetic events (Brown and Balmain, 1995; Balmain and Harris, 2000) . These events are divided into three independent stages: initiation, transformation, and progression. The ratelimiting events in multistage carcinogenesis are believed to occur during transformation and progression. Thus, identifying the speci®c signaling pathways in the ratelimiting step are important to prevent cell transformation as well as to inhibit tumor growth. Signal transducers and activators of transcription (STATs) are a group of latent cytoplasmic transcription factors primarily found in cytokine-regulatory genes. As intracellular eectors of cytokines and growth factor signaling pathways, STAT proteins function in the control of cell proliferation, dierentiation and apoptosis Danial et al., 1995; Yu et al., 1995; Darnell, , 1997 Bowman et al., 2000) . As such, binding of cytokines to their corresponding receptors is able to trigger a cascade of signaling pathways by activation of various protein tyrosine kinases including Janus kinases (JAKs) (Finbloom and Larner, 1995; Darnell, 1997; Hirano et al., 2000) . The activated JAKs by tyrosine phosphorylation then activate STATs, which are able to transactivate various cytokine-responsive genes through binding to the interferon gamma-activated (GAS) motifs in gene promoter regions to mediate their biological functions (Zhong et al., 1994; Larner and Reich, 1996; Chow et al., 2001) .
STAT signaling was ®rst identi®ed in v-src induced oncogenesis (Yu et al., 1995) . STAT3 mediated signaling pathways are required in signaling the transformation response induced by v-src oncoprotein, which can be blocked by a dominant negative STAT3 Bromberg et al., 1999) . Accumulating studies further supported the role of STATs in cell transformation and tumor formation (Danial et al., 1995; Besser et al., 1999; Demoulin et al., 2000) . For instance, activation of STAT3 has been detected in several human tumors including breast cancer, multiple myeloma, lymphomas, and head and neck carcinoma (Weber-Nordt et al., 1996; Garcia et al., 1997; Grandis et al., 1998; Catlett-Falcone et al., 1999) . Although dierent STAT proteins are activated by several oncogenes (Migone et al., 1995; Garcia and Jove, 1998) , STAT1a, STAT5, and STAT6 are found indirectly linked with malignant ®broblasts that are transformed by oncoproteins (Garcia et al., 1997) . In contrast, STAT3 has been proven to be an oncoprotein itself and required speci®cally for v-src induced transformation (Yu et al., 1995; Bromberg et al., 1998; Turkson and Jove, 2000) . Additional evidence further suggests that STAT3 but not STAT1 is required for EGF-induced cell growth (Grandis et al., 1998) . Although STAT3 is proven to be a speci®c transcription factor in cell transformation, its signaling function as a rate-limiting event in the progression of epithelial cell transformation remains to be elucidated.
IL-6 participates in the regulation of cell growth, dierentiation, and cell survival (Van Snick, 1990; Akira and Kishimoto, 1992; Sui et al., 1999) . IL-6 is able to function as a growth factor (Tosato et al., 1988) and its soluble receptors are involved in signaling the growth of normal, human papillomavirus immortalized, and carcinoma derived cervical cells (Iglesias et al., 1995) , which occurs via an autocrine mechanism (Tosato et al., 1988; Kawano et al., 1989) . IL-6 expression has also been con®rmed in multiple myeloma infected with Kaposi's sarcoma-associated herpes virus (KSHV) (Rettig et al., 1997) . In addition, overexpression of the growth-factor receptors ErbB2/neu and ErbB3 causes neoplastic transformation and IL-6 increases tyrosine phosphorylation of ErbB2 and ErbB3 in prostate cancer LNCaP cells (Qiu et al., 1998) . Stimulation of cells by IL-6 induces gp130, a shared signal transduction receptor for a family of cytokines (Chow et al., 2001 ), which in turn activates protein tyrosine kinases and transcription factors (Akira, 1997; Qiu et al., 1998) , including STAT3 (Akira et al., 1993; Zhong et al., 1994; Yu et al., 1998) . Any role of IL-6/STAT3 activation in signaling multistage carcinogenesis of epithelial cells is unknown.
To determine if the IL-6/STAT3 pathway acts as a key signaling event in tumor promotion, we studied the cell transformation response in JB6 mouse epidermal cells with tumor promotion sensitive (P+) or insensitive (P7 ) genetic variants that have been intensively studied as an in vitro model for identi®cation of critical genes during multistage carcinogenesis (Huang et al., 1996; Dong et al., 1997) . The present results demonstrate that STAT3 but not STAT1 was activated by IL-6 that caused anchorage-independent transformation in P+ but not P7 cells. Furthermore, expression of dominant negative mutant STAT3 blocked IL-6-induced STAT3 activity and abolished the transformation response. In addition, expression of wild type STAT3 restored both STAT3 activity and anchorage independent transformation. Finally, two matrix metalloproteinase genes are shown to be responsive to STAT3 activation.
Results

IL-6 promotes JB6 P+ cell transformation
Although many cytokines are known to promote tumor cell growth, it is not clear whether any single cytokine is able to initiate the progression of multistage carcinogenesis. Using JB6 mouse skin epithelial cells, here we show that anchorage-independent transformation was induced by IL-6 (100 ng/ml) in tumor promotion sensitive P+ cells but not in the resistant variant P7 cells. About fourfold anchorage-independent transformation was induced in P+ cells compared to the level of control P+ cells without IL-6 stimulation ( Figure 1a,b) . In contrast, no anchorage independent growth was induced in P7 cells. The dierent basal transformation levels of P+ and P7 cells without IL-6 exposure were the same as previously demonstrated (Li et al., 1996) .
IL-6 induced DNA-binding of STAT3 in P+ cells
Next, we determined DNA-binding activity of STAT3 by gel shift analysis with two radioactive-labeled oligonucleotides that bind to activated STAT1 and STAT3 (Oligo A) or to STAT6 (Oligo B) that was included as a control. DNA binding was analysed with the nuclear extracts of JB6 P+ and P7 cells after stimulation with IL-6 or EGF. Compared to control, IL-6 exposure (100 ng/ml, 15 min) strongly induced STAT3 but not STAT6 DNA-binding activity in P+ cells (Figure 2a ). STAT3 activation was also observed following exposure to IL-6 for 10 h. EGF (100 ng/ml) did not induce STAT3 activation following 15 min or 10 h exposure (Figure 2a,b) . In addition, activation of STATs was not detected in P7 cells following treatment with IL-6 or EGF for 15 min or 10 h. To con®rm transcription function, STAT3 was analysed using luciferase reporter controlled by the STAT3 speci®c promoter as described in Materials and methods. Consistent with the DNA binding activity, a 12-fold activation of STAT3 was detected in the P+ cells but not in P7 cells following IL-6 exposure ( Figure 2c ).
AP-1 has been well documented in signaling cell transformation especially induced by tumor promoter TPA (Bernstein and Colburn, 1989; Dong et al., 1994; Young et al., 1999) . AP-1 also plays an active role in signaling the transformation of P+ cells by TPA (Bernstein and Colburn, 1989; Dong et al., 1994) and the progression of human keratinocytes induced by human papillomavirus (Li et al., 1998 . To determine if AP-1 is also activated in the IL-6 induced transformation response, DNA-binding activity of AP-1 was measured with gel shift assays using nuclear proteins puri®ed from P+ and P7 cells with or without IL-6 exposure (100 ng/ml, 15 min). No signi®cant AP-1 activation was measured in either DNA binding or transcription activity (Figure 3a,b) . These results suggest that the signaling pathways induced by IL-6 are dierent from those induced by the chemical tumor promoter TPA.
IL-6 activated STAT3 but not STAT1
To gain further insight into whether STAT1 or STAT3 is speci®cally activated in IL-6 induced transformation, we determined STAT1 and STAT3 in the DNA binding complex induced by IL-6. Supershift analysis with antibodies to STAT1 and STAT3 (Figure 4 , lanes 5 and 6) show that STAT1 antibody slightly shifted the lower portion of the STAT3 complex (Figure 4 , lane 5). In contrast, STAT3 antibody completely shifted the DNA complex ( Figure 4 , lane 6). These results suggest that STAT3 is the major component of STATs in the STAT-DNA binding complex in IL-6 induced cell transformation. NF-kB has been identi®ed as a major transcription factor responsive to cytokines, and subunits of NF-kB, mainly p65, interact with other transcription factors in P+ cell transformation (Li et al., 1997) . We thus included antibodies to p65 and p50 in the gel shift analysis. Supershift results excluded the presence of p65 and p50 in the STAT3 DNA binding complex, thus suggesting that interaction between p65/p50 with STAT3 is unlikely ( Figure 4 , lanes 7 and 8). Therefore, in P+ cells, STAT3 appears to be a unique factor in signaling a cytokine induced transformation response.
Mutant STAT3 transfectants
Stable transfectants into P+ cells of two mutant forms of STAT3 gene (mutants in DNA binding mD or transcription domain mF) were accomplished with LipofectAMINE mediated transfection followed by selection with the medium containing the relevant antibiotic. To examine whether the dominant negative constructs of STAT3 are able to block IL-6-induced STAT3 activation, the luciferase reporter of STAT3 was transfected into the mutant STAT3 and control vector transfectants. Compared to the vector control cells, both dominant negative STAT3mF and STAT3mD dramatically inhibited IL-6-induced STAT3 activity ( Figure 5a ). The inhibition levels were slightly lower than the basal activity in mutant transfectants without cytokine stimulation. To con®rm the expression of mutant STAT3 genes, IP7 Western analysis showed that transgene marker HA was expressed in the mutant and control vector transfectants ( Figure 5b ). Compared to the vector control, the endogenous STAT3 protein was absent in the nucleus of both mutant STAT3 transfectants following IL-6 exposure ( Figure 5c , lanes 2 ± 5).
Anchorage independent transformation was abolished in mutant STAT3 transfectants
To elucidate if STAT3 transactivation is required for signaling IL-6-induced transformation, we compared the transformation response in mutant STAT3 and vector control transfectants of P+ cells. Compared to the vector control, transformation response was absent in the mutant STAT3F (mF) and STAT3D (mD) ( Figure 6 ). The basal anchorage independent transformation was also lowered in both mutant transfectants Anchorage-independent transformation. Cell transformation was measured in promotion sensitive P+ and resistant P7 JB6 cells using the anchorage-independent growth assay. Cells were collected using 0.033% trypsin, and suspended in 1.5 ml 7 0.33% agar EMEM over 7 ml 0.5% agar medium containing IL-6 (100 ng/ml). Anchorage independent colonies were scored after incubation at 368C for 14 days and results were normalized to the value of control P+ cells without IL-6 treatment. Data shown are means and s.e. from three experiments (**P50.05). (b) Growth of anchorageindependent colonies in P+ and P7 cells with or without IL-6. The conditions of anchorage-independent growth in soft agar culture was the same as described above. Colonies were stained after 14 days for both P+ and P7 cells cultured with or without IL-6 (22 ± 28% compared to the vector control; data not shown). These results are in agreement with reported data that transfection of the dominant negative STAT3 genes blocked IL-6-induced signal transduction. We further demonstrate here that blocking IL-6/STAT3 pathways by these mutant STAT3 is able to inhibit the transformation response in mouse skin epithelial cells (Shimozaki et al., 1997; Grandis et al., 1998) .
Two MMP genes targeted by STAT3 activation
Activation of matrix metalloproteinases is an important step in cell transformation as well as in the regulation of cell growth (Matrisian, 1994) . Collagenase I and stromelysin I were directly linked with gene expression responses in transformation of human keratinocytes . Stromelysin I also functions as an eector gene in signaling multistage carcinogenesis (Lochter et al., 1998; Sternlicht et al., 2000) . To determine if these matrix metalloproteinases are activated in STAT3-mediated epithelial cell transformation, we measured transcription levels of three MMP genes in mutant STAT3 and the control vector transfectants. Increased expression and protein levels of collagenase I were observed in the IL-6 treated vector control P+ cells (Figure 7a,b) . In contrast, mRNA
Figure 2 IL-6 but not EGF activated DNA binding of STAT3. P+ and P7 cells were cultured in 4% FBS EMEM and treated in EMEM with IL-6 (100 ng/ml) or EGF (100 ng/ml) for 15 min (a) or 10 h (b). DNA binding activity was measured with 3 mg nuclear extracts and 32 P7 labeled STAT oligonucleotides. Oligonucleotide A (Oligo A) contains one binding site for STAT3 or STAT1, and oligonucleotide B (Oligo B) contains one binding site for STAT6 used as a negative control. Electrophoresis was performed on 6% acrylamide gel and the DNA-proteins complex was visualized by exposure to X-ray ®lm. (c) STAT3 luciferase reporter transactivation. STAT3 luciferase and b-galactosidase reporters were co-transfected in P+ and P7 cells and luciferase activity was determined 36 h following IL-6 exposure (100 ng/ml for 15 min). STAT3 transactivation was normalized to the b-galactosidase reporter transactivation and the activity without IL-6 treatment. The results shown are means and s.e.m. of three experiments (**P50.05) levels in both basal and induced collagenase I was blocked in mutant mF and mD transfectants ( Figure  7a ). IL-6 induced protein levels were also inhibited in both mutant transfectants, although the mutant transfectants showed an elevated basal level of collagenase I (Figure 7b ). The basal and induced stromelysin I (mRNA and proteins) was also signi®-cantly down-regulated in the mutant STAT3 transfectants (Figure 7a,b) , and in comparison, IL-6 induced signi®cant stromelysin I expression in both mRNA and protein levels in vector control transfectants. Interestingly, expression of another MMP gene, gelatinase A, was not inhibited in the mutant STAT3 transfectants. These results thus indicate that speci®c matrix metalloproteinases responsive to IL-6/STAT3 signaling pathways are involved in the transformation induced in mouse epithelial cells. Potential functions of the STAT3 regulated matrix metalloproteinases in signaling multistage carcinogenesis are worthy to be elucidated.
Restoration of transformation response by transfection of wild type STAT3
To test whether the transformation response is directly linked with STAT3 activity, we transfected wild type STAT3 gene into mF transfectants, and the response of anchorage independent transformation and STAT3 activation were analysed in the mF+wild type STAT3 (mF+w) transfectants following IL-6 exposure. Interestingly, the anchorage independent transformation was totally restored in the mF+w STAT3 transfectants in responding to IL-6 stimulation ( Figure 8a ). Actually, the transformation level was more elevated than the basal level of vector control that showed a similar response compared to wild type P+ cells (Figure 8a compared to Figure 1a ). STAT3 dependent luciferase expression was also restored in the mF+w transfectants (Figure 8b) . Importantly, compared to the mF cells, protein expression levels of collagenase I and stromelysin I that were down-regulated in both mutant STAT3 transfectants (Figure 7a,b) were reexpressed in the mF+w transfectants with increased basal and induced levels following IL-6 exposure ( Figure 8c ).
Discussion
This study provides the ®rst evidence that activation of STAT3 is required in signaling transformation of mouse epithelial cells in dierent stages of multistage carcinogenesis. Using the JB6 cell transformation model with sensitive or resistant phenotype to several tumor promoters (Bernstein and Colburn, 1989; Dong et al., 1994; Li et al., 1997) , we show IL-6 induced DNA binding and transcriptional activity of STAT3 To make AP-1 binding in P-cells detectable, 3 mg nuclear proteins from P+ cells and 6 mg protein from P-cell were incubated with 32 P-labeled AP-1 oligonucleotides. The result shown is a representative of four independent experiments. (b) AP-1 dependent luciferase activity. AP-1 activity was measured using AP-1 luciferase reporter co-transfected with b-galactosidase reporters. The luciferase activity was determined 36 h following IL-6 exposure (100 ng/ml for 15 min), and the results were normalized to the b-galactosidase reporter transactivation. Results shown are means and s.e.m. of three experiments (**P50.05) Figure 4 STAT3 but not STAT1 was detected in the IL-6 induced STAT3/DNA complex. To determine components in the DNA-binding complex induced by IL-6, nuclear proteins were analysed with radioactive-labeled oligonucleotides and supershift was performed with the antibody speci®c to STAT1 or STAT3. Nuclear proteins were ®rst incubated with indicated antibodies followed by incubation with 3610 4 c.p.m .
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P-labeled oligonucleotides. DNA binding complex was separated in 6% acrylamide gel electrophoresis. Normal antiserum (nrs), antibody to p65 or p50, or 1006 cold oligonucleotides (control, ctr) were included as controls (one of three gel shift experiments) and anchorage independent transformation in tumor promotion sensitive P+ but not resistant P7 cells. In addition, mutant STAT3 genes blocked STAT3 activation and the transformation response induced by IL-6 in P+ cells. The requirement of STAT3 was further implicated by transfection of wild type STAT3 that restored STAT3 activity and the transformation response in the mutant STAT3 transfectants. Two matrix metalloproteinases, collagenase I and stromelysin I, appeared to be actively regulated in STAT3 induced epithelial cell transformation.
The present results strongly suggest a dierent signaling pattern of ligand-mediated cell transformation between tumor promotion sensitive and resistant mouse epithelial cells. The result of anchorageindependent transformation induced in tumor promotion sensitive cells but not the resistant variant indicates a ligand-mediated STAT3 activation required only for cells at the tumor promotion ready-stage. This is an important ®nding for the approach of identifying speci®c molecular targets at tumor promotion stage. Several cytokine ligands such as IFN-a, IL-2, IL-6, IL-7, IL-12 and IL-15, have been implicated in STAT3 activation with a pattern of cell type dependence (Sadowski et al., 1993; Johnston et al., 1995; Stancato et al., 1996; Takeda et al., 1998) . STAT3 is activated in human tumor samples and tumor cell lines, especially in oncogene-induced cell transformation (Bowman et al., 2000) . STAT3 activation is proven to be a key step for Src oncoprotein-mediated transformation, and this pathway is independent of v-ras induced transformation (Bromberg et al., 1998) . Expression of STAT3 has been shown to enhance the transforming potential of vsrc while three dominant negative STAT3 mutants inhibit the v-src induced transformation (Bromberg et al., 1998; , 2000) , the ligand-mediated STAT3 activation is worthy to be tested further as a key target event to block the progression of epithelial cell transformation.
The ligand-activated STAT3 is a necessary step for the transformation induced by inducible epidermal growth factor receptor and insulin-like growth factor I receptor (Zong et al., 1998) . However, experiments with EGF receptor-speci®c inhibitor have indicated that activation of STAT3 is not dependent on ligandreceptor activation, although EGF is shown to further increase STAT3 activation (Garcia et al., 1997) . These results suggest that activation of STAT3 can be ligand-dependent and independent, and both pathways can be activated during oncogenic transformation that activates speci®c tyrosine kinases (Garcia et al., 1997) . Our present results show that IL-6 but not EGF induced STAT3 activation in P+ but not P7 skin epithelial cells (Figure 2 ), suggesting that IL-6 is a speci®c ligand required for STAT3 activation necessary for transformation of mouse skin epithelial cells. The IL-6 induced transformation was, however, low Figure 6 Anchorage-independent transformation was inhibited in transfectants of two forms of mutant STAT3. P+ transfectants of mutant STAT3 genes as described in Materials and methods (mF or mD) and control vector, were cultured in complete medium. Anchorage-independent transformation was determined in soft agar medium containing 100 ng/ml of IL-6. Colonies formed 14 days after being cultured in soft agar were scored and data was normalized to the value of vector control without IL-6. The results represent the means and s.e.m. of three experiments (**P50.05) Figure 7 Expression of collagenase I and stromelysin I but not gelatinase A was down-regulated in mutant STAT3 transfectants. To determine the down stream genes in IL-6/STAT3 induced cell transformation, expression of matrix metalloproteinases collagenase I, stromelysin I, and gelatinase A were measured by RT ± PCR (a) and Western blot (b) in the mutant STAT3 (mF) and (mD) and vector control (V) transfectants with or without IL-6 treatment. GAPDH primers were internal controls for RT ± PCR. The RT ± PCR result shown is a representative of ®ve experiments and Western blot is one of two experiments compared with the eect of phorbol ester and TNF-a (Benedetti et al., 1990; Dong et al., 1994; Li et al., 1996) . In addition, IL-6 at lower concentrations did not show transformation activity (Benedetti et al., 1990) . Therefore, a dierent signaling pathway is required for STAT3 mediated transformation compared to that induced by phorbol ester. IL-6 induced transformation did not require AP-1 transactivation necessary for cells transformed by TPA or by human papilloma virus (Li et al., 1996 , which supports the concept of a unique STAT3 signaling pathway. However, similar to these tumor promoters (Bernstein and Colburn, 1989; Li, 1996; Dong et al., 1997) , transformation seen only in the sensitive P+ but not resistant P7 cells suggests that ligand-activated STAT3 may share a common signaling network with other tumor promoters. Elucidating the shared signaling pathway is important in an attempt to block the rate-limiting event during multistage carcinogenesis.
Activation of the endogenous IL-6 gene may be an essential step in multistage carcinogenesis of skin epithelial cells. Although IL-6 is regulated by a feedback control of JAK protein kinase (Lutticken et al., 1994) and STAT3 (Akira, 1997) , expression of IL-6 is controlled by a variety of transcription factors including AP-1 and NF-kB (Dokter et al., 1996; Xia et al., 1997) . Ionizing radiation has been reported to induce IL-6 expression via NF-kB activation (Beetz et al., 2000) . Our previous results suggest that radiation induces both AP-1 and NF-kB (Li et al., 2001) , and overexpression of manganese-containing superoxide dismutase (MnSOD) inhibits expression of the endogenous IL-6 via down-regulation of AP-1 and NFkB (Li et al., 1998) . Therefore, inhibition of tumor growth (Li et al., 1995) and blockage of cell (Amstad et al., 1991) achieved by overexpressing the anticancer antioxidant enzyme MnSOD could be explained by the down-regulation of IL-6/STAT3 pathways.
Activation of STAT3 has been shown to target Cyclin D1, c-Myc, and Bcl-x and blocking constitutive STAT3 expression results in growth inhibition and apoptosis of STAT3-positive tumor cells in vitro and in vivo . The present results indicate that matrix metalloproteinases are the down-stream targets of STAT3-mediated transformation in mouse skin epithelial cells. Matrix metalloproteinases are a group of zincdependent endopeptidases that degrade most extracellular matrix (Matrisian, 1994; Massova et al., 1998; Nagase and Woessner, 1999) . Matrix metalloproteinases have been indicated in the JAK-STAT pathways (Korzus et al., 1997) and v-src activation of the collagenase I promoter is mediated via PEA3 and STAT regulation (Vincenti et al., 1998) . In addition, we have reported that collagenase I and stromelysin I participate in the transformation of human keratinocytes induced by human papillomavirus and v-fos genes . Results have been reported that strongly support the requirement of stromelysin I in signaling carcinogenesis (Sternlicht et al., 2000) . Most importantly, activation of stromelysin is involved in signaling early stages of tumor promotion and the generation of a malignant tumor phenotype (Lochter et al., 1998) . Three matrix metalloproteinases involved in epithelial cell transformation and malignant tumor growth (Massova et al., 1998; Nagase and Woessner, 1999) were detected in the STAT3-mediated mouse skin transformation. Both basal and induced expression of collagenase I and stromelysin I was blocked in the mutant F and D STAT3 transfectants (Figure 7a,b) . In addition, collagenase I and stromelysin I down-regulated in both mutant transfectants were re-expressed at the protein level when the STAT3 activity was restored by transfection of the wild type STAT3 into the mutant STAT3 transfectant (Figure 8 ). It is important to note that transformation response was also restored. These results raise the possibility that the STAT3-mediated activation of matrix metalloproteinase plays a key role in the transformation of epithelial cells. However, we did not ®nd dierences in AP-1 activation between P+ and P7 cells, which excludes the possibility that modulation of matrix metalloproteinases is mediated by AP-1. Therefore, activation of both STAT3 and matrix metalloproteinases appears to be induced by a speci®c pathway required for the transformation of skin epithelial cells.
In conclusion, IL-6 transformed tumor promotion sensitive mouse skin epidermal cells but not the resistant variant. STAT3 but not STAT1 was specially activated by IL-6, and expression of mutant STAT3 genes inhibited STAT3 activation and the anchorage independent transformation. In addition, reconstitution of STAT3 by transfection of a wild type STAT3 restored the transformation response and induced expression of two matrix metalloproteinase genes inhibited by mutant STAT3. Therefore, STAT3 and a subset of matrix metalloproteinases are involved in the signaling network causing tumor promotion in mouse skin epithelial cells. 
Materials and methods
Reagents
Plasmids
Wild type HA-STAT3, mutant HA-STAT3F, HA-STAT3D, and control vectors were kindly provided by T Hirano (Shimozaki et al., 1997) . The STAT luciferase reporter construct was made with the reporter vector pGL2-basic (Promega, Madison, WI, USA) containing three-repeats of the SIE GAS motif that eciently binds to STAT3 (Yu et al., , 1999 . AP-1 luciferase reporters were constructed as described previously (Li et al., 1997) . CMV-neo-selecting plasmid (pBKCMV) and hygromycin-selecting plasmid (pCEP4) were obtained from Invitrogen Co. (San Diego, CA, USA). CMV-b-galactosidase plasmid was purchased from Clontech Laboratories, Inc. (Palo Alto, CA, USA).
Anchorage-independent transformation
IL-6-induced cell transformation was analysed in tumor promotion sensitive P+ and resistant P7 cells using the described anchorage-independent growth that has been shown to be irreversible and to correlate with tumorigenicity (Bernstein and Colburn, 1989) . Brie¯y, exponentially growing cells were washed three times with PBS and trypsinized with 0.033% trypsin and 0.13 mM EDTA. Cells were diluted and suspended in 1.5 ml 0.33% agar EMEM over 7 ml 0.5% agar medium containing IL-6 (100 ng/ml). The cultures were maintained at 368C and 1.0 ml fresh medium containing 100 ng/ml IL-6 was added every 3 days. Anchorage independent colonies were scored after incubation at 368C for 14 days. The anchorage independent growth in wild type cells and the eciency of inhibition in the mutant STAT3 transfectants were compared to the level of wild type P+ cells with or without IL-6 treatment.
Reporter transfection and luciferase assay
Transfection of luciferase reporters into JB6 mouse epidermal cells followed the published procedure (Li, 1996; Li et al., 1997) . Both P+ and P7 cells were plated in 24-well culture plates and cultured in 4% EMEM at 368C for 18 h (70 ± 80% con¯uence) before transfection. To measure transcription factor activities, 1610 4 cells were co-transfected by LipofectAMINE using 0.3 mg luciferase reporter DNA and 0.2 mg b-galactosidase reporters, followed by cytokine treatment. Cells were washed with PBS and lysed with 200 ml luciferase assay cell lysis buer (Promega, Madison, WI, USA). Luciferase activity was read on a luminometer using 100 ml cell lysate and an equal volume of luciferase substrate (Moonlight 2010, Analytical Luminescence Laboratory, San Diego, CA, USA).
Nuclear protein analysis
Nuclear proteins were prepared following published methods (Yu et al., 1996) . JB6 cells (5610 7 cells) collected after trypsinization were washed three times with PBS and resuspended in 1 ml cell lysis buer. The lysis mixture was then centrifuged at 48C for 1 min and the pellets were washed with 0.3*0.5 ml washing buer once by centrifuging at 48C for 1 min. The cell nuclei were then resuspended in 50 ± 100 ml nuclear protein extraction buer, centrifuged at 48C for 5 min, and supernatants were saved as nuclear proteins. The SIE GAS-like motif containing oligonucleotide: 5'-AGCTTGTCGACATTTCCCGTAAATCGTCGG-3' and Ce GAS-like motif containing oligonucleotide: 5'-AGTCAA-GACCTTTTCCCAAGAAATCTATC-3' were used to detect the STAT/DNA-binding activity (Yu et al., 1996 . Oligonucleotides containing the motif for control transcription factor AP-1: 5'-AGCATGAGTCAGACACCT-CTGGC-3' were purchased from Promega. Gel shift analysis was performed with 1 ± 3 mg nuclear proteins in 20 ml DNA binding buer. The reaction mixture was incubated on ice for 10 min and then further incubated for 20 min at room temperature after adding 5610 4 c.p.m .
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P-labeled oligonucleotide probe. The DNA-protein complexes were electrophoresed for 2 h at room temperature in nondenaturing acrylamide gel. For supershift assays, nuclear extracts were incubated with antibodies at room temperature for 20 min and then reacted with radioactive-labeled DNA oligonucleotide for another 20 min. The supershift complexes were detected by non-denaturing acrylamide gel.
Establishment of the STAT mutant cell lines
JB6 P+ cells with 60% con¯uence in 100 mm dishes were transfected using LipofectAMINE with 30 mg mutant STAT3 plasmids HA-STAT3F and HA-STAT3D together with 2 mg hygromycin-selecting plasmid pCEP4. Selection for 10 ± 14 days with 10 ± 20 mg/ml hygromycin produced no colonies in the control P+ cells without transfection while producing 20*30 clones in the HA-mutant and HA-vector controls. The selected cells were pooled and cultured for at least ®ve passages with 10 mg/ml hygromycin, and experiments were performed with transfected cells free of hygromycin. Response to IL-6-induced transformation was tested by anchorage-independent growth in soft agar. To establish stable transfectants of wild type STAT3 cell lines, HA-STAT3 vector was co-transfected with pcDNA3 plasmids into HA-STAT3F (MutantF) transfectants and stable transfectants were obtained by G418 selection. Experiments were performed in medium without selecting drugs.
Immunoprecipitation and Western blotting
For immunoprecipitations, whole cell lysate (120 mg total protein) was precleaned with 50 ml agarose beads conjugated with nonspeci®c rabbit IgG (Sigma Co.) and reacted with 5 mg/ml STAT3 antibodies. Reactions were gently agitated overnight at 48C and bound complexes were pelleted by centrifuge at 48C for 10 min followed by washing three times with 0.01% Tween PBS. The bound proteins were mixed with 50 ml loading buer, heated at 708C for 10 min, size separated in 12.5% acrylamide SDS ± PAGE, and transferred to PVDF protein blot membrane (Millipure Co., Bedford, MA, USA). The protein membrane was then blocked at room temperature for 2 h in blocking solution (Pierce Co., Rockford, IL, USA), washed with 0.01% Tween PBS, and incubated overnight at 48C at 1 : 300 dilution of antibody. The membrane was visualized with the ECL Western blot detection solution (Amersham Co., Arlington Heights, IL, USA).
RT ± PCR
Total RNA was extracted by using TRIzol Reagent (Life Technologies, Inc., Gaithersburg, MD, USA). After con®rmation of integrity on an agarose gel, total RNA was digested with RNase-free DNase I for 20 min, extracted using phenol-chloroform, and then precipitated with 2.5 volume ethanol. cDNA was synthesized in a reaction volume of 20 ml buer containing 0.1 mg total RNA, 100 pmol of random hexadeoxynucleotides (Promega Co., Madison, WI, USA) and 200 units moloney murine leukemia virus reverse transcriptase (MMLV-RT, Gibco/BRL, Gaithersburg, MD, USA). For PCR reactions, 5 ml cDNA products were mixed in reaction buer (Promega) containing 2.0 units Taq DNA polymerase (Promega) and 0.1 mM of following primers for MMP genes designed with Genbank database: Collagenase I (MMP-13; Genbank #: NM_008607; 349 bp fragment): AGGCCTTCAGAAAAGCCTTC (forward); GAAATGGC-TTTTGCCAGTGT (backward); Stromelysin I (MMP-3; Genbank #: NM_010809; 407 bp fragment): TCAGTAC-CTTCCCAGGTTCG (forward), AGCCTTGGCTGAGT-GGTAGA (backward); Gelatinase A (MMP-2; Genbank #: 008610; 406 bp fragment): GCACTCTGGAGCGAGGA-TAC, CACATCCTTCACCTGGTGTG (backward). Fragments were enhanced by 25 ± 35 cycles.
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